
A medical device positioning strategy that starts with messaging and skips category definition is solving the wrong problem first. The category has to exist in the buyer's mind before any positioning statement can land.
Key Takeaways

Founders default to assuming a strong product will position itself. It won't, and this specific failure mode shows up more than any other in medtech.
I covered this on an episode about how market engineering helps medtech startups raise capital, where I called a solution without a market the most common thing I see in medtech:
"You can have a really incredible technology, but you don't have a defined category. And the mistake is thinking that if we build something great, they will come. It's just not how it happens. In order to persuade, you have to put context into things."
That context is the category. Without it, a buyer has no framework for evaluating why the product matters, no matter how strong the underlying technology is.
A positioning strategy that skips this step describes a product to a market that hasn't been told what kind of product it's looking at.

Positioning strategy typically fails at the messaging stage, and founders often misdiagnose that as a copywriting problem when the cause is sequencing.
I covered the sequence on the same episode:
"Your category is defining the problem, naming the category. Messaging is your positioning, your differentiation, your proofs."
Messaging sits downstream of category. If the category was never defined, messaging has nothing solid to differentiate against, and every positioning statement ends up vague by necessity.
Founders who keep rewriting their messaging without revisiting the category underneath it are patching the wording on a foundation that was never laid. No amount of copy editing fixes a category that was never named.

Even when founders do the category work, some default to positioning inside a category an incumbent already owns. That choice hands the terms of the competition to someone else before the positioning work even starts.
I interviewed Bruce Cleveland on an episode about product-market fit, category design, and why startups waste funding. He said:
"You don't want to compete in an existing category if you can possibly help it, because somebody else there is the category leader and they define the terms of competition."
Cleveland helped create the "enterprise AI" category as a CMO. He describes measuring whether a category is taking hold by counting analyst mentions, publication pickups, conference mentions, and searches for the term.
A medical device positioning strategy built inside an incumbent's category is playing a game with rules the incumbent wrote. Positioning against a category you define yourself changes what the buyer is even comparing you to.

The founders who position most effectively become the recognized authority on the problem itself.
On an episode about why medtech marketers must focus more on top of funnel, the speaker described Christopher Lockhead's category design approach. It calls for a strong, divisive point of view and becoming the number one marketer of the category and the problem.
Product marketing describes features and benefits. Category and problem ownership means becoming the source buyers reference when they're trying to understand the problem at all, before they've evaluated any specific product.
A positioning strategy aimed at the product alone competes on comparison. A positioning strategy aimed at owning the problem sets the terms other companies get compared against.
In my experience working with medtech founders, positioning gets treated as a messaging exercise more often than it should, and that framing skips the category work that determines whether the messaging lands.
The founders who get this right start with category before copy. They name the problem and the category before writing a single positioning line, because messaging built on an undefined category has nothing solid to stand on.
They also avoid competing inside categories incumbents already own, and they aim their positioning at owning the problem itself instead of describing their product's place within someone else's frame.
A medical device positioning strategy is only as strong as the category underneath it. Skip that step, and even the best messaging is describing a product the market doesn't yet have a framework to evaluate.
Category definition should come first. A category names the problem and sets the context a buyer uses to evaluate any product. Without it, positioning messaging has nothing specific to differentiate against, and it tends to read as generic no matter how well written it is.
Starting with messaging means writing differentiation for a category the buyer has not been shown.
Vague positioning usually comes from skipped category work. Messaging sits downstream of category in the sequence, so undefined category work shows up as unclear differentiation in the messaging built on top of it.
Rewriting the copy alone does not clear that up until the category underneath the messaging has a name.
Creating or redefining a category is generally the stronger position when it's achievable, because the incumbent in an existing category already controls the terms of comparison. Positioning inside their category means competing on rules someone else wrote.
Bruce Cleveland's version is that the category leader already defines the terms of competition, so a company entering that category starts on someone else's ground.
If you're doing this yourself. Read the medtech commercialization strategy breakdown to see where category and positioning work fits inside the full sequence founders need before go-to-market.
If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For founders revisiting their positioning, the audit checks whether the category underneath it has been defined.
Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialisation strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.